CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- DEFM14A Deal DEFM14A
- PREM14A Deal PREM14A
- DEFA14A Proxy Proxy Materials
- SC 13G/A Stake Amended Statement of Ownership
- 8-A12G/A Other 8-A12G/A
- 8-K Event Material agreement · Shareholder rights changed
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- 10-Q Report Quarterly Report
- 8-K Event Delisting notice
- 10-K/A Report 10-K/A
- 8-K Event Exit or restructuring costs
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change
Page 55 of 68 · 1,358 filings